![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/485 | (2006.01) |
A61K 31/137 | (2006.01) | ||
A61P 25/24 | (2006.01) | ||
A61P 25/28 | (2006.01) | ||
A61P 25/02 | (2006.01) |
(11) | Number of the document | 3220909 |
(13) | Kind of document | T |
(96) | European patent application number | 15861189.7 |
Date of filing the European patent application | 2015-05-01 | |
(97) | Date of publication of the European application | 2017-09-27 |
(45) | Date of publication and mention of the grant of the patent | 2020-09-02 |
(46) | Date of publication of the claims translation | 2021-01-25 |
(86) | Number | PCT/US2015/028901 |
Date | 2015-05-01 |
(87) | Number | WO 2016/081027 |
Date | 2016-05-26 |
(30) | Number | Date | Country code |
201414550618 | 2014-11-21 | US | |
201414554988 | 2014-11-26 | US | |
201414554947 | 2014-11-26 | US | |
201414555085 | 2014-11-26 | US | |
201514602177 | 2015-01-21 | US | |
201514604397 | 2015-01-23 | US | |
201514617624 | 2015-02-09 | US | |
201514628062 | 2015-02-20 | US |
(72) |
TABUTEAU, Herriot, US
|
(73) |
Antecip Bioventures II LLC,
630 Fifth Avenue, Suite 2000, New York, NY 10111,
US
|
(74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Bupropionas, skirtas vaisto dekstrometorfano lygio moduliavimui plazmoje |
BUPROPION FOR MODULATING DRUG PLASMA LEVELS OF DEXTROMETORPHAN |
Payment date | Validity (years) | Amount | |
2025-04-10 | 11 | 289.00 EUR |
2026-05-01 |